Evidence map›Paper›PMID 23512600›Full record

ArticleObesity (Silver Spring, Md.)2014

Serum hepcidin levels are associated with obesity but not liver disease.

Raj Vuppalanchi, Jason S Troutt, Robert J Konrad, Marwan Ghabril, Romil Saxena, Lauren N Bell, Kris V Kowdley, Naga Chalasani

Open access · greenAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. The role of iron metabolism in chronic diseases related to obesity.Molecular medicine (Cambridge, Mass.) · 2022
    Review
  6. Article
  7. Essential role of systemic iron mobilization and redistribution for adaptive thermogenesis through HIF2-α/hepcidin axis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Article
  9. Hepcidin Levels and Pathological Characteristics in Children with Fatty Liver Disease.Pediatric gastroenterology, hepatology & nutrition · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Iron and liver fibrosis: Mechanistic and clinical aspects.World journal of gastroenterology · 2019
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Raj VuppalanchiDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Jason S Troutt
Robert J Konrad
Marwan Ghabril
Romil Saxena
Lauren N Bell
Kris V Kowdley
Naga Chalasani
Indiana University School of MedicineEli Lilly (United States) · USIndiana University – Purdue University Indianapolis · USVirginia Mason Medical Center · US

Funding

Patient-Oriented Research of Liver DiseaseK24DK069290 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CHALASANI, NAGA P · 2005 to 2014
$1.4M
NIDDK NIH HHS K24 DK069290
6 · The paper itself

Abstract

objectiveHepcidin is regulated by anemia and inflammation. It is primarily expressed in the liver but studies have reported its expression in adipose tissue. The relationship between BMI and serum hepcidin and the relationship between liver histology and serum hepcidin in the morbidly obese was investigated.

methodsSerum and liver tissue from patients undergoing bariatric surgery (bariatric cohort, n = 105) and serum from healthy blood donors (n = 60) were used to conduct this study. Serum hepcidin was measured using sandwich ELISA, highly specific for hepcidin-25. Serum ferritin, IL-6, IL-1β and liver function biochemistries were also measured.

resultsAfter controlling for covariates, BMI ≥ 35 kg/m(2) was significantly associated with higher serum hepcidin level compared to individuals with lower BMI groups (17.7 ± 11.5 vs. 3.3 ± 4.7 ng/ml, P = 0.002). The presence of NAFLD was not associated with higher serum levels of hepcidin (multivariate P = 0.37). There was no association between serum hepcidin levels and liver histology (presence of steatohepatitis, advanced fibrosis, or NAFLD activity score) in the bariatric cohort.

conclusionsObesity, but not the presence of NAFLD was associated with serum hepcidin levels. There was no association between serum hepcidin and liver histology in the morbidly obese undergoing bariatric surgery.

Indexed as

AdultBariatric SurgeryBody Mass IndexCohort StudiesFatty LiverFemaleFerritinsHepcidinsHumansInterleukin-1betaInterleukin-6Linear ModelsLiverLiver DiseasesMaleMiddle AgedFerritinsHepcidinsInterleukin-1betaInterleukin-6

Identifiers

PMID23512600
PMCPMC3692602
OpenAlexW1518665512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.